ResMed Long Term Deferred Assets (Quarterly) Analysis

ResMed, Inc. (RMD)

257.58 -3.12 (-1.20%) USD | NYSE | Jan 16, 16:00

257.57 -0.01 (-0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for RMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Boston Scientific Corp.	Upgrade
Abbott Laboratories	--
Stryker Corp.	Upgrade
West Pharmaceutical Services, Inc.	Upgrade
Insulet Corp.	--